Wheeler DC, Stefánsson BV, Jongs N, Chertow GM, Greene T, Hou FF, McMurray JJV, Correa-Rotter R, Rossing P, Toto RD, Sjöström CD, Langkilde AM, Heerspink HJL. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial. Lancet Diabetes Endocrinol. 2021;9(1):22–31.

Article  CAS  PubMed  Google Scholar 

Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, Mann JFE, McMurray JJV, Lindberg M, Rossing P, Sjöström CD, Toto RD, Langkilde AM, Wheeler DC. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436–46.

Article  CAS  PubMed  Google Scholar 

Wu J, Che Y, Zhang Y, Wang J, Chen M, Jiang J, Jiang Q, Zhou Y. Global, regional, national trends of femur fracture and machine learning prediction: comprehensive findings and questions from global burden of disease 1990–2019. J Orthop Translat. 2024;46:46–52.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Wang K, Zhu J, Wu J. A network suspected infectious disease model for the development of syphilis transmission from 2015 to 2021 in Hubei province, China. J Appl Microbiol. 2023;134(12).

Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248–60.

Article  CAS  PubMed  Google Scholar 

Wu J, Wang K, Tao F, Li Q, Luo X, Xia F. The association of blood metals with latent tuberculosis infection among adults and adolescents. Front Nutr. 2023;10:1259902.

Article  PubMed  PubMed Central  Google Scholar 

Jinyi W, Zhang Y, Wang K, Peng P. Global, regional, and national mortality of tuberculosis attributable to alcohol and tobacco from 1990 to 2019: a modelling study based on the Global Burden of Disease study 2019. J Glob Health. 2024;14:04023.

Article  PubMed  PubMed Central  Google Scholar 

Bonner R, Albajrami O, Hudspeth J, Upadhyay A. Diabetic kidney disease. Prim Care. 2020;47(4):645–59.

Article  PubMed  Google Scholar 

Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R. Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: The FIDELITY Analysis. Diabetes Care. 2022;45(12):2991–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Filippatos G, Anker SD, Pitt B, Rossing P, Joseph A, Kolkhof P, Lambelet M, Lawatscheck R, Bakris GL, Ruilope LM, Agarwal R. Finerenone and heart failure outcomes by kidney function/albuminuria in chronic kidney disease and diabetes. JACC Heart Fail. 2022;10(11):860–70.

Article  CAS  PubMed  Google Scholar 

Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care. 2005;28(1):164–76.

Article  PubMed  Google Scholar 

Shixiang L. Analysis of the effect of individualized hemodialysis on the incidence of complications in patients with end-stage diabetic nephropathy. Chinese Medicine Guide. 2018;16(5):101.

Google Scholar 

Yang Guangshu, Fan Jihui, Zhu Jiang EA. Effects of hemodialysis on iPTH and inflammatory factors in patients with diabetic nephropathy. Journal of Hunan Normal University (Medical Edition). 2015;12(2):81–83.

Xie Jingjing, Jin Dong, Shuguang. G. Analysis of the clinical effect of hemodialysis treatment in patients with end-stage diabetic nephropathy. New World of Diabetes. 2023;26(4):184–187.

Guoyu R. The effectiveness of maintenance hemodialysis in the treatment of diabetic nephropathy and its influence on their quality of life. New world of diabetes. 2021;24(2):175–7.

Google Scholar 

Yujing D. Analysis of the therapeutic effect of hemodialysis on patients with diabetic nephropathy and the influence of insulin and C-peptide levels. Application of modern drugs in China. 2018;12(9):49–50.

Google Scholar 

Pan Huafang, Yin Jinfeng, Wei. Y. Effect of hemodialysis on iPTH and inflammatory factors in patients with diabetic nephropathy. Dialysis and artificial organs. 2021;32(4):9–10.

Zheng Y, Xiaoli X. End-stage efficacy and complications of hemodialysis in the treatment of diabetic nephropathy. Contemporary medicine. 2018;24(6):15–7.

Google Scholar 

Li WH, Yin YM, Chen H, Rui ZR, Yuan Y, Yun H, Wang JW. Clinical research on individualized hemodialysis preventing unconventional hypotension in diabetic nephropathy patient. Int J Artif Organs. 2020;43(4):229–33.

Article  PubMed  Google Scholar 

Ruilope LM, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, Schmieder RE, Joseph A, Rethemeier N, Nowack C, Bakris GL. Blood pressure and cardiorenal outcomes with finerenone in chronic kidney disease in type 2 diabetes. Hypertension. 2022;79(12):2685–95.

Article  CAS  PubMed  Google Scholar 

Waijer SW, Sen T, Arnott C, Neal B, Kosterink JGW, Mahaffey KW, Parikh CR, de Zeeuw D, Perkovic V, Neuen BL, Coca SG, Hansen MK, Gansevoort RT, Heerspink HJL. Association between TNF receptors and KIM-1 with kidney outcomes in early-stage diabetic kidney disease. Clin J Am Soc Nephrol. 2022;17(2):251–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DeFronzo RA, Reeves WB, Awad AS. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat Rev Nephrol. 2021;17(5):319–34.

Article  CAS  PubMed  Google Scholar 

Filippatos G, Bakris GL, Pitt B, Agarwal R, Rossing P, Ruilope LM, Butler J, Lam CSP, Kolkhof P, Roberts L, Tasto C, Joseph A, Anker SD. Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes. J Am Coll Cardiol. 2021;78(2):142–52.

Article  CAS  PubMed  Google Scholar 

Pérez-Morales RE, Del Pino MD, Valdivielso JM, Ortiz A, Mora-Fernández C, Navarro-González JF. Inflammation in diabetic kidney disease. Nephron. 2019;143(1):12–6.

Article  PubMed  Google Scholar 

Blanken A, Agca R, Popa CD, Nurmohamed M. AB0238 serum levels of E-selectin and IL-8 decrease after 6 months of anti-inflammatory therapy and mirror favorable vascular changes in rheumatoid arthritis. Ann Rheumatic Dis. 2020;79:1419.

Article  Google Scholar 

Muth KN, Rech J, Losch FO, Hoerning A. Reversing the Inflammatory Process-25 Years of Tumor Necrosis Factor-α Inhibitors. J Clin Med. 2023;12(15):5039.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Havrdova T, Heerspink HJL, Kooy A, Laverman GD, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Petrie JR, Ruggenenti PL, Rutters F, Rychlík I, Siwy J, Spasovski G, Speeckaert M, Trillini M, Zürbig P, von der Leyen H, Rossing P. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial. Lancet Diabetes Endocrinol. 2020;8(4):301–12.

Article  CAS  PubMed  Google Scholar 

Tesař V. SGLT2 inhibitors in non-diabetic kidney disease. Adv Clin Exp Med. 2022;31(2):105–7.

Article  PubMed  Google Scholar 

Sasso FC, Pafundi PC, Simeon V, De Nicola L, Chiodini P, Galiero R, Rinaldi L, Nevola R, Salvatore T, Sardu C, Marfella R, Adinolfi LE, Minutolo R. Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease. Cardiovasc Diabetol. 2021;20(1):145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zamarrón E, Jaureguizar A, García-Sánchez A, Díaz-Cambriles T, Alonso-Fernández A, Lores V, Mediano O, Troncoso-Acevedo F, Cabello-Pelegrín S, Morales-Ruíz E, Ramírez-Prieto MT, Valiente-Díaz MI, Gómez-García T, Casitas R, Martínez-Cerón E, Galera R, Cubillos-Zapata C, García-Río F. Continuous positive airway pressure effect on albuminuria progression in patients with obstructive sleep apnea and diabetic kidney disease: a randomized clinical trial. Am J Respir Crit Care Med. 2023;207(6):757–67.

Article  PubMed  Google Scholar 

Lunyera J, Diamantidis CJ, Bosworth HB, Patel UD, Bain J, Muehlbauer MJ, Ilkayeva O, Nguyen M, Sharma B, Ma JZ, Shah SH, Scialla JJ. Urine tricarboxylic acid cycle signatures of early-stage diabetic kidney disease. Metabolomics. 2021;18(1):5.

Article  PubMed  Google Scholar 

Wang Y, Xu X, Shi S, Gao X, Li Y, Wu H, Song Q, Zhang B. Blood urea nitrogen to creatinine ratio and long-term survival in patients with chronic heart failure. Eur J Med Res. 2023;28(1):343.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shikata K, Haneda M, Ninomiya T, Koya D, Suzuki Y, Suzuki D, Ishida H, Akai H, Tomino Y, Uzu T, Nishimura M, Maeda S, Ogawa D, Miyamoto S, Makino H. Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan). J Diabetes Investig. 2021;12(2):207–16.

Article  CAS  PubMed  Google Scholar